Subscribe via RSS Feed Connect with us on LinkedIn

New Research Study: How Breast Augmentation Patients Respond to EXPAREL

Share on Facebook1Tweet about this on Twitter1Google+1

A new research study came to light a few days ago regarding the response of patients that opted for Breast Augmentation to a pain reliever called EXPAREL!

Dr. Poulos and Dr. Hvistendahl, two renowned plastic surgeons based on the San Fransisco Bay Area, conducted a study on EXPAREL in order to find whether this pain reliever provides an improved and more comfortable patient experience The study participants, women from Napa and Santa Rosa, agreed to get free silicone implants for breast augmentation in exchange for their participation to the study (which saved them $2000)!

A few words on EXPAREL before revealing the conclusions of the study! EXPAREL is a topical pain killer which includes an anesthetic. This medication is used in the pocket where the breast implant is inserted! An obvious advantage of this option is that it isn’t an opiate-based pain reliever!

exparel

The study showed a 72-hour post-treatment relief which makes it no necessary for oral pain relief medication to be used! This is because the formula of EXPAREL allows a gradual application of the anesthetic for a long period of time!

Dr. Poulos says: “Our research involving EXPAREL is consistent with the approach to plastic surgery we’ve taken throughout our careers,”

The two plastic surgeons have also utilized many other innovative techniques including Quicklift (an efficient mini-facelift technique), Venus Legacy and (the best non-surgical liposuction alternative according to our latest study) Coolsculpting (more information can be found right here)!

Dr. Hvistendahl concludes: “We believe that healthy lifestyle choices are an integral part of a patient’s overall well-being and should be part of the practice of cosmetic enhancement,” and adds “Feeling good inside and looking good outside really go hand-in-hand.”

Your Opinion?

Rate this Article

Leave a Reply

You must be logged in to post a comment.